The Foundation Board of the Fonds fuer versuchstierfreie Forschung (FFVFF, now Animalfree Research) established an annual award for the best article published in ALTEX in 1997. ALTEX Edition, founded in 2006, continues to bestow the award annually.

The Doerenkamp-Zbinden Foundation has generously sponsored the ALTEX Award, which entails a personal prize of CHF 2.000, since 2014.

The members of the Board of ALTEX Edition, the ALTEX Editorial Board and ALTEX Editorial Office elect the winner of the annual prize out of all main articles published in the previous year; articles including members of the ALTEX Board and Editorial Office as first or last authors are excluded.

The award is presented to the first author of the article at an international conference.


ALTEX Award Winners

Uwe Marx et al., TissUse GmbH, Berlin, Germany
Biology-inspired microphysiological system approaches to solve the prediction dilemma of substance testing.
ALTEX 33, 272-321.

Heike A. Behrensdorf-Nicol et al., Paul-Ehrlich Institute, Langen, Germany
“BINACLE” assay for in vitro detection of active tetanus neurotoxin in toxoids.
ALTEX 32, 137-142.

Sarah E. Cavanaugh et al., Physicians Committee for Responsible Medicine, Washington, D.C., USA
Animal models of Alzheimer disease: historical pitfalls and a path forward.
ALTEX 31, 279-302.

Miriam N. Jacobs et al., European Food Safety Authority, Parma, Italy
In vitro metabolism and bioavailability tests for endocrine active substances: What is needed next for regulatory purposes?
ALTEX 30, 331-351.

Fransisca Leonard et al., Saarland University, Saarbruecken, Germany
Screening of budesonide nanoformulations for treatment of inflammatory bowel disease in an inflamed 3D cell-culture model.
ALTEX 29, 275-285.

Erwin van Vliet, CAAT, Johns Hopkins University, Baltimore, USA
Current standing and future prospects for the technologies proposed to transform toxicity testing in the 21st century.
ALTEX 28, 17-44.

Phillip B. Kuegler, Doerenkamp-Zbinden Chair for in vitro toxicology and Biomedicine, University of Konstanz, Germany
Markers of murine embryonic and neural stem cells, neurons and astrocytes: reference points for developmental neurotoxicity testing.
ALTEX 27, 17-42.

Costanza Rovida, Private Consultant, Varese, Italy
Re-evaluation of animal numbers and costs for in vivo tests to accomplish REACH legislation requirements for chemicals - a report by the Transatlantic Think Tank for Toxicology (t4).
ALTEX 26, 187-208.

Thomas Hartung, CAAT, Johns Hopkins University, Baltimore, USA
Food for thought …. on animal tests.
ALTEX 25, 3-9.


Marcel Leist, Doerenkamp-Zbinden Chair for in vitro toxicology and Biomedicine, University of Konstanz, Germany
The biological and ethical basis of the use of human embryonic stem cells for in vitro test systems or cell therapy.
ALTEX 25, 163-190.

Marie-Jeanne W. A. Schiffelers et al., Utrecht University, Utrecht School of Governance (USG), The Netherlands
Factors stimulating or obstructing the implementation of the 3Rs in the regulatory process.
ALTEX 24, 271-278.

Arianna Ferrari, Technical University of Darmstadt, Darmstadt, Germany
Genetically modified laboratory animals in the name of the 3Rs?
ALTEX 23, 294-307.

Marion Krug et al., Paul-Ehrlich Institute, Langen, Germany
Serological test methods as replacement for infection trials in piglets to test the potency of E. coli vaccines for sows (dams).
ALTEX 22, 111-116.

Mahtab Bahramsoltani and Johanna Plendl, Free University, Berlin, Germany
Ein neues in vitro Modell zur Quantifizierung der Angiogenese.
ALTEX 21, 227-244.

Oliver Reuthebuch et al., University Hospital, Zurich, Switzerland
Vollsynthetisches Trainingsmodell für die Koronarchirurgie: die Abkehr von Tierversuchen?
ALTEX 20, 17-20.

Nina Schweigert et al., EAWAG, Swiss Federal Institute for Environmental Science and Technology, Duebendorf, Switzerland
Ecotoxicological assessment of surface waters: a modular approach integrating in vitro methods.
ALTEX 19, Suppl., 1, 30-37.

Heinrich W. Grosse, Pastoralsoziologisches Institut (PSI) der Evangelischen Fachhochschule Hannover, Germany
Christliche Verantwortung und Experimentelle Medizin. Versuche mit und am Menschen, Tierversuche.
ALTEX 19, 195-202.

Christiane Gindorf et al., Across Barriers GmbH, Saarbruecken, Germany
Markertransport über biologische Barrieren in vitro: Vergleich von Zellkulturmodellen für die Dünndarmschleimhaut, die Blut-Hirn Schranke und das Alveolarepithel der Lunge.
ALTEX 18, 155-164.

Cornelia B. Reininger Vascular Center, University of Munich, Germany
The cell function analyser (CFA) – a physiological in vitro vascular model and potential alternative to animal experiments.
ALTEX 17, 115-125.

Guntolf Herzberg, Berlin, Germany
Was kann „ethisches Abwägen“ im Tierversuch bedeuten?
ALTEX 16, 255-266.

No award

Elvira Ebert et al., Paul-Ehrlich Institute, Langen, Germany
Serologische Wirksamkeitsprüfung von Clostridium perfringens-betatoxoidhaltigen Veterinärimpfstoffen - eine Alternative zum gesetzlich vorgeschriebenen Mäuseneutralisationstest.
ALTEX 13, 68-75.
Optimierung und Etablierung von serologischen Methoden für die Wirksamkeitsprüfung von Immunglobulinen gegen Clostridium tetani-Toxoid.
ALTEX 15, Suppl., 30-32.
Entwicklung und Prävalidierung yon Alternativmethoden zur Wirksamkeitsprüfung von Clostridium perfringens-Impfstoffen.
ALTEX 15, Suppl., 59-61.